Scarica l'app Stockscreener
10.89
4.93%
-0.565
Immucell Corp Borsa (ICCC) Ultime notizie
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand - Yahoo Finance
ImmuCell Corporation Files Form 8-K: Key Financial Data and Company Information for July 2026 - Minichart
ImmuCell reports 11.5% sales increase in second quarter - Investing.com
ImmuCell (ICCC) Reports Significant Growth in Quarterly Sales - GuruFocus
ImmuCell reports Q2 product sales up 11.5% to $7.2M; six‑month sales up 20.9% to $17.5M - TradingView
ImmuCell (ICCC) Q2 2026 sales hit $7.2M as six-month revenue climbs 20.9% - Stock Titan
ImmuCell sales jump 12% in Q2 as U.S. demand lifts calf products - Stock Titan
ImmuCell adds Jacee Lancaster to Commercial Team - Feedstuffs
ImmuCell Corporation (ICCC) Gains 1.39% as Stock Approaches Key Resistance at $10.70Inverse ETF Flow - dars.gov.et
ICCC's valuation remains premium: Is it worth overpaying for? - MSN
The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCell - Yahoo Finance
ImmuCell Corp (ICCC) Institutional Confidence - TradingKey
ImmuCell CEO buys $75,960 in common stock - Investing.com UK
Insider Buying: te Boekhorst Paul Francis Olivier Acquires Additional Shares of ImmuCell Corp (ICCC) - GuruFocus
Form 4 ImmuCell Corporation For: 22 June By Investing.com - Investing.com Nigeria
ImmuCell CEO buys $75,960 in common stock By Investing.com - Investing.com Canada
ImmuCell (ICCC) CEO increases stake with 8,000-share open-market buy - Stock Titan
ImmuCell Corp (ICCC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ImmuCell Corp (ICCC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ImmuCell Corp (ICCC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ICCC's Valuation Remains Premium: Is it Worth Overpaying for? - The Globe and Mail
ImmuCell shareholders approve director elections and key proposals at annual meeting - Investing.com
ImmuCell (NASDAQ: ICCC) investors approve directors, pay plan, auditor - Stock Titan
ImmuCell Corp (ICCC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ImmuCell Corp (ICCC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ImmuCell Corp (ICCC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ImmuCell Corp (ICCC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ImmuCell Corp (ICCC) Valuation: PE, PB & Fair Value Analysis - TradingKey
ImmuCell (NASDAQ: ICCC) approves $3.5M First Defense expansion plan - Stock Titan
Jonathan Ocampo joins ImmuCell Commercial Team - Feedstuffs
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
ImmuCell Corp. Hits New 52-Week High of $10.65, Up 145% - MarketsMojo
ImmuCell Corporation (ICCC) Surges 3.75% to $10.50 as Bulls Test Key ResistanceNews Sentiment - The Legal Advocate
ImmuCell Shares Rose Ahead of Holiday; Tuesday’s Open in Focus - Bez Kabli
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand - Yahoo Finance
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ImmuCell Corporation (ICCC) Climbs +10.76% — Resistance at $10.37 in Focus 2026-05-18Median Line - newsline.com
ImmuCell Corporation (NASDAQ:ICCC) Q1 2026 Earnings Call Transcript - Insider Monkey
ImmuCell Q1 Earnings Call Highlights - sharewise.com
Earnings call transcript: ImmuCell Q1 2026 marks milestone with revenue surge - Investing.com
ImmuCell (NASDAQ: ICCC) posts strong Q1 2026 growth, higher margins and cash - Stock Titan
ImmuCell (NASDAQ: ICCC) grows Q1 2026 revenue 28% and boosts earnings - Stock Titan
Calf-health maker ImmuCell secures $2M to expand First Defense output - Stock Titan
ImmuCell Corporation 2025 10-K/A Annual Report Filing Details, Address, and SEC Cover Information - Minichart
ImmuCell (NASDAQ: ICCC) files 10-K amendment to update exhibit list - Stock Titan
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity - Yahoo Finance
TradingKey - TradingKey
ImmuCell | 4: Statement of changes in beneficial ownership of securities-Director Basse Gloria F - Moomoo
ImmuCell Reaches Settlement Agreement with Norbrook Laboratories - The Globe and Mail
ImmuCell Corporation Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Key Entity Information - Minichart
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):